Stay updated on REGN668 Safety in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the REGN668 Safety in Atopic Dermatitis Clinical Trial page.

Latest updates to the REGN668 Safety in Atopic Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe ClinicalTrials.gov page footer reflects an updated site revision, with no change to the study details.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe ClinicalTrials.gov page now displays the study record for REGN668 in patients with atopic dermatitis, including its design, eligibility criteria, locations, and outcomes, instead of a 403 error.SummaryDifference42%

- Check22 days agoChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check29 days agoChange DetectedA banner announces NIH website updates and explains that federal agencies are transitioning to the term “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check36 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check43 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the study page continued to show a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to REGN668 Safety in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the REGN668 Safety in Atopic Dermatitis Clinical Trial page.